Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addentax (ATXG) Common Equity (2016 - 2025)

Addentax has reported Common Equity over the past 11 years, most recently at $21.6 million for Q4 2025.

  • Quarterly Common Equity fell 9.16% to $21.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.6 million through Dec 2025, down 9.16% year-over-year, with the annual reading at $21.7 million for FY2025, 16.57% down from the prior year.
  • Common Equity was $21.6 million for Q4 2025 at Addentax, down from $25.9 million in the prior quarter.
  • Over five years, Common Equity peaked at $26.8 million in Q3 2023 and troughed at -$81498.0 in Q1 2021.
  • The 5-year median for Common Equity is $23.4 million (2022), against an average of $17.0 million.
  • The largest YoY upside for Common Equity was 493105.27% in 2022 against a maximum downside of 115.83% in 2022.
  • A 5-year view of Common Equity shows it stood at -$21808.0 in 2021, then skyrocketed by 105143.82% to $22.9 million in 2022, then increased by 5.83% to $24.2 million in 2023, then decreased by 1.78% to $23.8 million in 2024, then decreased by 9.16% to $21.6 million in 2025.
  • Per Business Quant, the three most recent readings for ATXG's Common Equity are $21.6 million (Q4 2025), $25.9 million (Q3 2025), and $25.2 million (Q2 2025).